CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new antimicrobial peptides to combat antibiotic-resistant infections. These peptides disrupt bacterial cell membranes and show promise against resistant strains, with the goal of advancing them toward clinical testing as effective therapeutics.
Antimicrobial resistance (AMR) is a critical global health threat, associated with approximately 5 million deaths annually and a severe economic burden.
To combat this threat, this project aims to advance the development of our de novo designed antimicrobial peptides (AMPs) towards novel therapeutics.
These AMPs, developed within our ERC Consolidator project "Peptide Killers of Bacteria", utilize a mechanism distinct from traditional antibiotics, namely the disruption of bacterial cell membranes…
Masarykova univerzita
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
